TITLE

Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

PUB. DATE
January 2011
SOURCE
Pediatric Rheumatology;2011, Vol. 9 Issue 1, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents case report of a 22-month-old girl with Systemic juvenile idiopathic arthritis (sJIA) who developed severe Macrophage activation syndrome (MAS). The patient was successfully treated with corticosteroids, cyclosporin A, and non-steroidal anti-inflammatory drugs by monitoring serum IL-18 levels. It is reported that IL-18 is an important cytokine for monitoring the activity of sJIA and MAS.
ACCESSION #
65280906

 

Related Articles

  • Hemophagocytic syndrome in adult-onset Still's disease (AOSD): A must for biologics?-Case report and brief review of the literature. Bürgi, Urs; Mendez, Adriana; Hasler, Paul; Hüllstrung, Hans // Rheumatology International;Oct2012, Vol. 32 Issue 10, p3269 

    A case of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis is reported. Its management is being discussed on the background of the latest literature with special regard on the use of high-dose corticosteroids and immunosuppressive agents.

  • Off-label use common for DED. Krader, Cheryl Guttman; Cunningham, Derek N. // Optometry Times;Oct2011, Vol. 3 Issue 9, p30 

    The article highlights the off-label treatment for dry eye disease (DED) particularly anti-inflammatory agents appropriate for patients with level 2 or greater severity using a four-level rating scheme. Although approved for keratoconjunctivitis sicca, topical cyclosporine 0.05% ophthalmic...

  • S100 Calgranulins in inflammatory arthritis. Perera, Chandima; McNeil, H Patrick; Geczy, Carolyn L. // Immunology & Cell Biology;Jan2010, Vol. 88 Issue 1, p41 

    Calgranulins comprise three proteins, S100A8 (Calgranulin A), S100A9 (Calgranulin B) and S100A12 (Calgranulin C) that are predominantly expressed by neutrophils, monocytes and activated macrophages. These S100 calcium-binding proteins are important molecular mediators in a range of diseases,...

  • EFFECTS OF INHALED GLUCOCORTICOSTEROIDS TREATMENT ON CLINICAL AND EOSINOPHILIC INFLAMMATORY PARAMETERS IN PATIENTS WITH BRONCHIAL ASTHMA. Jovanović, Saša; Đorđević, Vidosava; Ćosić, Vladan // Acta Medica Medianae;Mar2010, Vol. 49 Issue 1, p43 

    Inhaled glucocorticosteroids are the most efficient anti-inflamatory drugs used in asthma treatment that can bring the improvement of clinical symptoms as well as lung function. Eosinophils (Eo) are the key efector cells in asthmatic inflammation, and determination of their number and...

  • Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates. Freeman, Hugh James // Clinical Medicine Insights: Gastroenterology;2012, Issue 5, p77 

    Medical management of ulcerative colitis has continued to evolve over more than half of a century. Perhaps, the important advance was the development of sulfasalazine, a drug initially used for the treatment of inflammatory joint disease and only later in the treatment of inflammatory bowel...

  • Oh, My Aching Joints! Crabbe, Barb // Horse & Rider;Oct2012, Vol. 51 Issue 10, p52 

    The article offers information on the causes, diagnosis, and treatment for joint disease in horses. It offers a brief information on the structure of joints including joint capsule, synovial fluid, and subchondral bone. It discusses various methods for diagnosis including radiography, ultrasound...

  • Treatment of refractory adult-onset still's disease with tocilizumab: report of two cases and review of the literature. Thonhofer, Rene; Hiller, Manuela; Just, Horst; Trummer, Markus; Siegel, Cornelia; Dejaco, Christian // Rheumatology International;Dec2011, Vol. 31 Issue 12, p1653 

    Adult-onset Still's disease (AOSD) is empirically treated with nonsteroidal anti-inflammatory drugs, corticosteroids, conventional disease-modifying antirheumatic drugs, tumor necrosis factor-blocking agents or anakinra. The monoclonal anti-interleukin (IL)-6 antibody tocilicumab (TOC) has...

  • Tocilizumab for the treatment of adult-onset Still's disease: results from a case series. Cipriani, Paola; Ruscitti, Piero; Carubbi, Francesco; Pantano, Ilenia; Liakouli, Vasiliki; Berardicurti, Onorina; Giacomelli, Roberto // Clinical Rheumatology;Jan2014, Vol. 33 Issue 1, p49 

    Adult-onset Still's disease (AOSD) is a chronic inflammatory disease of unknown etiology which commonly affects young adults. Treatment of AOSD patients includes nonsteroidal anti-inflammatory drugs, corticosteroids, and DMARDs. Interleukin (IL)-6 blockade is an attractive therapeutic option for...

  • Cyclosporine potentially effective as off-label anti-inflammatory.  // Primary Care Optometry News;Dec2012, Vol. 17 Issue 12, p8 

    The article provides information on a study which found cyclosporine potentially as effective as off-label anti-inflammatory.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics